Drug prices soar after pharma giants GSK and Sanofi exit Nigeria

Last October, Idoma Prince visited a pharmacy in Nigeria’s capital city of Abuja to replace his old inhaler but he returned home empty-handed.

The 24-year-old user interface designer was shocked after he was told the cost of a Ventolin inhaler, which he uses for his asthma, was now 8,500 Nigerian naira ($5.34). He returned home with the thoughts of the shocking price looming in his mind. Just a few months before, he had bought the same product for 3,500 naira ($2.46).

“I wasn’t prepared for that [price] at all so I had to delay getting it till I had enough money on me. This January I went to get [it] again and I saw that the price had gone up to 10,000 naira ($7.02) for one inhaler,” he told Devex.

This article is free to read - just register or sign in

Access news, newsletters, events and more.

Join us